NMDs represent a major cause of mortality and morbidity in children and adults. NMDs collectively affect an estimated 500,000 EU citizens and result in significant costs for families and healthcare systems. Many institutions and organisations, including the MRC Centre for Neuromuscular Diseases, have reduced the gap between science discoveries and patient benefit by establishing a multidisciplinary translational research activity in these disabling disorders. The MRC Centre for Neuromuscular Diseases is a partnership between the UCL Institutes of Child Health and Institute of Neurology, and the University of Newcastle upon Tyne and is one of the MRC’s translational research centres in the UK.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...